PUBLISHER: The Business Research Company | PRODUCT CODE: 1942523
PUBLISHER: The Business Research Company | PRODUCT CODE: 1942523
Cardiac valves are artificial devices designed to regulate the flow of blood within the heart, ensuring unidirectional blood movement from the heart to other parts of the body. These implantable devices play a crucial role in replacing damaged valves that may have ceased functioning due to various diseases. The primary objective of cardiac valves is to maintain the proper flow of blood through the heart and into the major blood vessels connected to it.
The primary types of cardiac valves include tissue valves, transcatheter valves, mechanical valves, and other variations. Tissue heart valves, utilized in open-heart or minimally invasive surgeries, aim to prevent blood clot formation inside the vessels. These valves are crafted from durable and flexible animal tissue obtained from donors and are employed in cardiac valve repair and replacement procedures. Various positions in the heart, such as the aortic valve and mitral valve, necessitate the repair or replacement of cardiac valves. End-users of cardiac valves include hospitals, clinics, specialty centers, cardiac research institutes, and other healthcare facilities.
Tariffs are influencing the cardiac valve market by increasing costs of imported biomaterials, precision metal components, manufacturing equipment, and sterilization systems used in mechanical and tissue valves. Hospitals and specialty cardiac centers in North America and Europe are most affected due to reliance on imported valve products, while Asia-Pacific faces higher production input costs. These tariffs are raising procedure expenses and procurement budgets. However, they are also supporting domestic valve manufacturing, regional innovation, and localized production of advanced cardiac valve solutions.
The cardiac valve market research report is one of a series of new reports from The Business Research Company that provides cardiac valve market statistics, including cardiac valve industry global market size, regional shares, competitors with a cardiac valve market share, detailed cardiac valve market segments, market trends and opportunities, and any further data you may need to thrive in the cardiac valve industry. This cardiac valve market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The cardiac valve market size has grown rapidly in recent years. It will grow from $12.41 billion in 2025 to $14.24 billion in 2026 at a compound annual growth rate (CAGR) of 14.8%. The growth in the historic period can be attributed to rising incidence of valvular heart diseases, expansion of cardiac surgery programs, growing use of mechanical heart valves, advancements in surgical valve techniques, increasing availability of cardiac care facilities.
The cardiac valve market size is expected to see rapid growth in the next few years. It will grow to $24.02 billion in 2030 at a compound annual growth rate (CAGR) of 14.0%. The growth in the forecast period can be attributed to increasing demand for transcatheter interventions, rising focus on elderly cardiac care, expansion of hybrid cardiac procedures, growing investments in next-generation valve technologies, increasing adoption of patient-specific valve solutions. Major trends in the forecast period include increasing adoption of transcatheter valve procedures, rising demand for bioprosthetic heart valves, growing preference for minimally invasive valve replacement, expansion of advanced valve repair techniques, enhanced focus on valve durability and performance.
The increasing prevalence of cardiovascular diseases is poised to drive the growth of the cardiac valve market. Factors such as smoking, obesity, lack of physical activity, and other cardiovascular stressors contribute to a gradual rise in cardiovascular diseases. Coronary artery disease, characterized by the build-up of fatty plaques in arteries, is a common cause. This surge in heart-related ailments has heightened the demand for cardiac valves to address heart valve issues. As of September 2023, data from the World Health Organization indicates that cardiovascular diseases account for a substantial portion, approximately 74%, of global deaths related to non-communicable diseases (NCDs) or chronic conditions.
Major players in the cardiac valve market are advancing transfemoral transcatheter mitral valve replacement (TMVR) systems to address the growing demand for minimally invasive therapies in patients with mitral regurgitation. TMVR systems use collapsible frames and biologic valve leaflets delivered via catheter through the femoral vein, avoiding open-heart surgery and reducing recovery time and procedural risk. In April 2025, Edwards Lifesciences received CE Mark approval for the SAPIEN M3 System, featuring a docking mechanism for stable leaflet capture and precise bioprosthetic valve deployment, enabling repositioning and retrieval to improve safety and expand treatment to patients ineligible for surgery or edge-to-edge repair.
In July 2024, Edwards Lifesciences acquired JenaValve Technology for an upfront USD 500 million, with up to USD 445 million in contingent payments, to expand its cardiac valve portfolio and strengthen its position in aortic regurgitation treatment. The acquisition allows Edwards to integrate JenaValve's Trilogy transcatheter heart valve system, enhancing its offerings in minimally invasive structural heart therapies. JenaValve's expertise in transcatheter valve technologies supports Edwards' strategic growth in high-risk patient populations, reflecting a broader trend in the cardiac device market toward acquisitions that advance portfolio diversification and innovative solutions for complex valve disease.
Major companies operating in the cardiac valve market are Abbott Laboratories, Edwards Lifesciences Corporation, Medtronic plc, Artivion Inc., Meril Life Sciences Pvt Ltd, Lepu Medical Technology Co Ltd, TTK Healthcare Limited, Braile Biomedica, JenaValve Technology Inc., Xeltis AG, Colibri Heart Valve LLC, On-X Life Technologies Inc., Thubrikar Aortic Valve Inc., LifeNet Health Inc., Auto Tissue Berlin GmbH, CryoLife Inc., LivaNova PLC, Foldax Inc., Micro Interventional Devices Inc., InnovHeart Srl
North America was the largest region in the cardiac valve market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cardiac valve market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the cardiac valve market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The cardiac valve market consists of sales of tricuspid valves and pulmonary valves. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Cardiac Valve Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses cardiac valve market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for cardiac valve ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cardiac valve market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.